Successful pharma companies are adapting commercialisation strategies to align with transformation in healthcare delivery. Vintura’s Richard Ogborne and Chris Reynolds provide practical guidance as to…
One definition of patient-centricity is “Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best…
COVID-19 disrupted and redefined the structure of life science congresses – large annual meetings where HCPs and drug and device developers come together to exchange…
As data becomes more important than documents when it comes to regulatory submissions and operational decision-making, there is a renewed focus on data quality. Amplexor’s…
Medical affairs teams should engage opinion leaders to shape products and help them reach a target market. This engagement constitutes developing relationships with clinicians and…
Pharma’s role in healthcare is changing amid the rise in more-targeted treatments and a shift in emphasis to preventative medical interventions. Gérard Klop of Vintura…
With our growing dependence on social media over the past decade, Digital Opinion Leaders–or “DOLs” for short–are becoming an increasingly important stakeholder group for Pharma…
On May 17th, 500+ of pharma’s clinical innovation will come together for the home of clinical collaboration, Reuters Events: Pharma Clinical 2022, to set new…
Novel and Advanced Therapies have made great strides over the past decade but that means that manufacturing process consistency, GMP standards and so on must…
Biopharma start-ups need to identify the best data-management processes and systems – but to do so means they need to avoid the mistakes made by…
